Dr. Evan Lewis
Adult & Child Neurologist
|Concussion/Post-Concussion| |Epilepsy| |Functional Neurological Disorder| |Functional Seizures|
|Cannabis & Psychedelic Medicine - Counselling & Therapy|
Comprehensive & Evidence-Based Neurologic Care
Dr. Lewis prioritizes harm reduction and recognizes the significance of how mental health impacts neurologic diagnoses.
He leverages his expertise in neurology to integrate emerging therapies, delivering individualized, comprehensive neurologic care.
Dr. Lewis’ patient visits occur at Watson Medical Clinic.
561 Eglinton Ave. West
Toronto ON
M5N 1B5
Tel: 416-551-7606
Fax: 647-689-2012
To schedule an appointment, contact the clinic directly or download a referral form for your health team to complete.
For existing patients, contact the clinic to book a follow up.
Note: all new patients require a referral from a physician or nurse practitioner
Schedule an Appointment with Dr. Lewis
Overview
Dr. Evan Cole Lewis is a Neurologist and Clinical Neurophysiologist with expertise in pediatric neurology and epilepsy. He is an Assistant Professor (Adjunct) with the Department of Pediatrics at the Hospital for Sick Children and the University of Toronto. He currently works as a consultant neurologist for both adults and children at Watson Medical Clinic and conducts clinical research trials at North Toronto Neurology in Toronto, Canada. Dr. Lewis’ clinical work focuses on epilepsy; concussion & persisting symptoms after concussion; functional neurological disorder, in particular functional seizures; and cannabis and psychedelic therapies for neurologic disorders.
Dr. Lewis was the founder of the Neurology Centre of Toronto where he served as medical director from 2016 to 2024. He served as VP Psychedelic Neurology for Numinus from 2021 to 2024 and is the current Chief Medical Advisor for the Jamaican Medical Cannabis Corporation Group.
Dr. Lewis’ research interests lie in the fields of psychedelic and cannabis therapies for neurologic disorders.
Work in Psychedelic Medicines
Dr. Lewis’ clinical and research focus in psychedelic medicine includes indications, treatment and novel approaches. He has clinical experience counselling patients with underlying neurologic conditions who have utilized psychedelics such as psilocybin, MDMA and ketamine. Dr. Lewis utilizes psychedelic-assisted therapy as adjunct treatment for functional neurological disorders, functional seizures, persistent post-concussive symptoms, depression, anxiety disorders and OCD in adolescents, co-morbid mental health conditions and special circumstances that arise from neurologic diagnoses. He has delivered educational seminars, talks and lectures on the intersection of psychedelics in neurology both locally and internationally.
Work in Medical Cannabis
Dr. Lewis has significant clinical experience with medical cannabis in adults and children and has spoken extensively on cannabis in neurologic disorders nationally and internationally. He is a member of the Cannabinoid Research Initiative of Saskatchewan (CRIS) and the Canadian Childhood Cannabinoid Clinical Trials (C4T) group. Dr. Lewis is a co-investigator on two medical cannabis trials, one targeting chronic headaches among adolescents and the other employing cannabis to address drug-resistant epilepsy in both children and adults.
In the United Kingdom, he is a member of the Expert Committee of the Medical Cannabis Clinicians Society (MCCS) and an advisor for the Medical Cannabis Working Group for Drug Science, Intractable Epilepsy Charity and MedCan.
Link to Publications: https://goo.gl/yLhvN1
